Black Rock Inc. G1 Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,082,031 shares of GTHX stock, worth $22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,082,031

Previous 672,027 358.62%

Holding current value

$22 Million

Previous $2.9 Million 142.06%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.2 - $4.98 $5.3 Million - $12 Million	2,410,004 Added 358.62%	3,082,031 $7.03 Million
Q1 2024 May 10, 2024	SELL	$2.1 - $4.83 $18,137 - $41,716	-8,637 Reduced 1.27%	672,027 $2.9 Million
Q4 2023 Feb 13, 2024	SELL	$1.12 - $3.73 $492,400 - $1.64 Million	-439,643 Reduced 39.24%	680,664 $2.08 Million
Q3 2023 Nov 13, 2023	SELL	$1.22 - $2.67 $79,712 - $174,452	-65,338 Reduced 5.51%	1,120,307 $1.61 Million
Q2 2023 Aug 11, 2023	SELL	$2.46 - $3.14 $495,082 - $631,934	-201,253 Reduced 14.51%	1,185,645 $2.95 Million
Q1 2023 May 12, 2023	SELL	$2.57 - $8.16 $271,420 - $861,785	-105,611 Reduced 7.08%	1,386,898 $3.72 Million
Q4 2022 Feb 13, 2023	SELL	$5.19 - $13.5 $140,898 - $366,498	-27,148 Reduced 1.79%	1,492,509 $8.1 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $777,443 - $2.55 Million	150,376 Added 10.98%	1,519,657 $19 Million
Q2 2022 Aug 12, 2022	SELL	$4.04 - $8.51 $7.8 Million - $16.4 Million	-1,930,568 Reduced 58.5%	1,369,281 $6.76 Million
Q1 2022 May 12, 2022	SELL	$7.6 - $11.02 $78,758 - $114,200	-10,363 Reduced 0.31%	3,299,849 $25.1 Million
Q4 2021 Feb 10, 2022	BUY	$10.16 - $16.17 $692,170 - $1.1 Million	68,127 Added 2.1%	3,310,212 $33.8 Million
Q3 2021 Nov 09, 2021	BUY	$13.16 - $22.47 $162,118 - $276,807	12,319 Added 0.38%	3,242,085 $43.5 Million
Q2 2021 Aug 11, 2021	BUY	$19.57 - $26.32 $63.2 Million - $85 Million	3,229,766 New	3,229,766 $70.9 Million

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account